Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)
27
presentations
5
followers
4
more
presentations
in this session
PARAGLIDEHF: Sacubitril/Valsartan versus valsartan on changes in NTproBNP, safety, and tolerability in patients with EF>40% stabilized after a WHF Event